Eiko LifeSciences Limited (BOM:540204)

Eiko LifeSciences Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	80.87	117.81	133.46	6.12	2.17	40.72
Short-Term Investments	-	-	-	-	-	24.72
Cash & Short-Term Investments	80.87	117.81	133.46	6.12	2.17	65.44
Cash Growth	158.22%	-11.73%	2079.30%	181.82%	-96.68%	1241.42%
Accounts Receivable	145.35	107.86	131.34	71.06	45.62	34.15
Other Receivables	-	-	-	-	-	3.96
Receivables	145.35	107.86	131.34	71.06	45.62	38.11
Inventory	20.99	57.75	33.86	9.08	54.58	0.64
Prepaid Expenses	-	-	0.06	0.6	0.19	-
Other Current Assets	36.69	45.36	10.57	6.16	31.95	2.83
Total Current Assets	283.9	328.77	309.29	93.01	134.51	107.02
Property, Plant & Equipment	226.1	231.19	135.65	138.81	142.89	2.48
Long-Term Investments	72.05	71.54	40.18	11.76	58.67	20.29
Long-Term Deferred Tax Assets	-	-	-	-	-	0.24
Other Long-Term Assets	20	29.51	41.42	43.7	-	-
Total Assets	647.6	661.01	527.39	310.43	348.94	166.14
Accounts Payable	17.19	33.15	13.81	10.45	13.49	18.95
Accrued Expenses	6.01	3.13	0.33	0.86	0.65	3.17
Short-Term Debt	-	7.55	-	-	45	16.31
Current Portion of Long-Term Debt	-	-	-	0.54	0.75	0.68
Current Income Taxes Payable	5.54	2.36	0.64	-	-	0.49
Other Current Liabilities	5.07	16.47	0.27	0.14	0.18	-
Total Current Liabilities	33.8	62.65	15.05	11.99	60.06	39.6
Long-Term Debt	10.09	20.08	-	-	0.54	1.28
Long-Term Deferred Tax Liabilities	9.62	8.21	5.56	4.22	2.05	-
Other Long-Term Liabilities	0	0	-	-	-0	-
Total Liabilities	53.51	90.95	20.61	16.21	62.64	40.88
Common Stock	137.21	137.63	128.73	83.16	83.16	38.2
Additional Paid-In Capital	-	375.2	344.06	184.58	184.58	12
Retained Earnings	-	55.06	34	26.48	18.56	11.66
Comprehensive Income & Other	450.58	-0	-	-	-	63.4
Total Common Equity	587.78	567.89	506.78	294.22	286.3	125.26
Minority Interest	6.3	2.18	-	-	-	-
Shareholders' Equity	594.08	570.06	506.78	294.22	286.3	125.26
Total Liabilities & Equity	647.6	661.01	527.39	310.43	348.94	166.14
Total Debt	10.09	27.63	-	0.54	46.28	18.27
Net Cash (Debt)	70.78	90.17	133.46	5.59	-44.1	47.18
Net Cash Growth	161.60%	-32.44%	2288.33%	-	-	-
Net Cash Per Share	5.24	6.92	12.94	0.57	-5.65	12.35
Filing Date Shares Outstanding	13.79	13.86	13.86	8.32	8.32	3.83
Total Common Shares Outstanding	13.79	13.86	13.86	8.32	8.32	3.83
Working Capital	250.1	266.11	294.24	81.03	74.45	67.42
Book Value Per Share	42.62	40.97	36.56	35.38	34.43	32.73
Tangible Book Value	587.78	567.89	506.78	294.22	286.3	125.26
Tangible Book Value Per Share	42.62	40.97	36.56	35.38	34.43	32.73
Buildings	-	53.41	38.57	38.29	38.11	-
Machinery	-	87.85	89.7	87.28	85.2	5.15
Leasehold Improvements	-	28.63	28.63	27.88	27.88	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.